PHASE 3 PRISM CLINICAL TRIAL EVALUATING EFFICACY AND SAFETY OF PEGVALIASE FOR TREATMENT OF ADULTS WITH PHENYLKETONURIA

被引:0
|
作者
Thomas, J. [1 ]
Levy, H. [2 ]
Amato, S. [3 ]
Vockley, G. [4 ]
Zori, R. [5 ]
Dimmock, D. [6 ]
Harding, C. [7 ]
Bilder, D. [8 ]
Weng, H. H. [9 ]
Olbertz, J. [9 ]
Merilainen, M. [9 ]
Jiang, J. [9 ]
Gupta, S. [9 ]
Gu, Z. [9 ]
Larimore, K. [9 ]
Northrup, H. [10 ]
机构
[1] Univ Colorado, Sch Med, Aurora, CO USA
[2] Boston Childrens Hosp, Boston, MA USA
[3] Univ Kentucky, Lexington, KY USA
[4] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA
[5] Univ Florida, Gainesville, FL USA
[6] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[7] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[8] Univ Utah, Salt Lake City, UT USA
[9] BioMarin Pharmaceut Inc, Novato, CA USA
[10] Univ Houston, Sch Med, Houston, TX USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
115
引用
收藏
页码:270 / 270
页数:1
相关论文
共 50 条
  • [1] PRISM 301: AN OPEN-LABEL, RANDOMIZED, PHASE 3 CLINICAL TRIAL EVALUATING EFFICACY AND SAFETY OF PEGVALIASE FOR THE TREATMENT OF ADULTS WITH PHENYLKETONURIA
    Longo, Nicola
    Amato, Stephen
    Vocldey, Jerry
    Wierenga, Klaas
    Li, Hong
    Bilder, Deborah
    Burton, Barbara
    Dimmock, David
    Harding, Cary
    Posner, John
    Thomas, Janet A.
    Zori, Roberto
    Greblikas, Feriandas
    Gu, Zhonghua
    Merilainen, Markus
    Weng, Haoling H.
    Levy, Harvey
    [J]. MOLECULAR GENETICS AND METABOLISM, 2016, 117 (03) : 268 - 268
  • [2] PHASE 3 PRISM CLINICAL TRIALS: EVALUATING CHANGE IN DIET WITH PEGVALIASE TREATMENT IN ADULTS WITH PHENYLKETONURIA
    Rohr, Fran
    Burton, Barbara K.
    Longo, Nicola
    Thomas, Janet A.
    Harding, Cary O.
    Rosen, Orli
    Gu, Zhonghu
    Olbertz, Joy
    Weng, Haoling H.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2019, 126 (03) : 323 - 323
  • [3] PHASE 3 PRISM CLINICAL TRIALS: EVALUATING CHANGE IN DIET WITH PEGVALIASE TREATMENT IN ADULTS WITH PHENYLKETONURIA
    Rohr, Fran
    Burton, Barbara K.
    Longo, Nicola
    Thomas, Janet A.
    Harding, Cary O.
    Rosen, Orli
    Gu, Zhonghu
    Olbertz, Joy
    Weng, Haoling H.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2019, 127 (03) : 296 - 297
  • [4] EFFICACY AND SAFETY OF THE RECOMMENDED PEGVALIASE DOSING REGIMEN IN ADULTS WITH PHENYLKETONURIA IN THE PHASE 3 PRISM STUDIES
    Sacharow, Stephanie
    Northrup, Hope
    Whitehall, Kaleigh Bulloch
    Rowell, Richard
    Lindstrom, Kristin
    Burton, Barbara
    Thomas, Janet
    [J]. MOLECULAR GENETICS AND METABOLISM, 2022, 135 (04) : 296 - 297
  • [5] Evaluating change in diet with pegvaliase treatment in adults with phenylketonuria: Analysis of phase 3 clinical trial data
    Rohr, Fran
    Burton, Barbara
    Dee, Anne
    Harding, Cary O.
    Lilienstein, Joshua
    Lindstrom, Kristin
    Macleod, Erin
    Rose, Sarah
    Singh, Rani
    van Calcar, Sandra
    Whitehall, Kaleigh
    [J]. MOLECULAR GENETICS AND METABOLISM, 2024, 141 (03)
  • [6] Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)
    Thomas, Janet
    Levy, Harvey
    Amato, Stephen
    Vockley, Jerry
    Zori, Roberto
    Dimmock, David
    Harding, Cary O.
    Bilder, Deborah A.
    Weng, Haoling H.
    Olbertz, Joy
    Merilainen, Markus
    Jiang, Joy
    Larimore, Kevin
    Gupta, Soumi
    Gu, Zhonghua
    Northrup, Hope
    [J]. MOLECULAR GENETICS AND METABOLISM, 2018, 124 (01) : 27 - 38
  • [7] Efficacyand safety of the recommended pegvaliase dosing regimen in adults with phenylketonuria in the phase 3 PRISM studies
    Lindstrom, K.
    Sacharow, S.
    Northrup, H.
    Whitehall, K. B.
    Rowell, R.
    Burton, B.
    Thomas, J.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2022, 136 : S23 - S23
  • [8] SUBGROUP ANALYSIS OF PEGVALIASE IN ADULTS WITH PHENYLKETONURIA IN PHASE 3 PRISM STUDIES: EVALUATING EFFICACY AND SAFETY BASED ON PREVIOUS SAPROPTERIN RESPONSE OR DIETARY PHENYLALANINE INTAKE
    Vockley, Jerry
    Zori, Roberto
    Thomas, Janet A.
    Stuy, Mary
    Burton, Barbara K.
    Longo, Nicola
    Rosen, Orli
    Gu, Zhonghu
    Olbertz, Joy
    Weng, Haoling H.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2019, 126 (03) : 332 - 332
  • [9] SUBGROUP ANALYSIS OF PEGVALIASE IN ADULTS WITH PHENYLKETONURIA IN PHASE 3 PRISM STUDIES: EVALUATING EFFICACY AND SAFETY BASED ON PREVIOUS SAPROPTERIN RESPONSE OR DIETARY PHENYLALANINE INTAKE
    Vockley, Jerry
    Zori, Roberto
    Thomas, Janet A.
    Stuy, Mary
    Burton, Barbara K.
    Longo, Nicola
    Rosen, Orli
    Gu, Zhonghu
    Olbertz, Joy
    Weng, Haoling H.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2019, 127 (03) : 308 - 308
  • [10] Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials
    Gupta, Soumi
    Lau, Kelly
    Harding, Cary O.
    Shepherd, Gillian
    Boyer, Ryan
    Atkinson, John P.
    Knight, Vijaya
    Olbertz, Joy
    Larimore, Kevin
    Gu, Zhonghu
    Li, Mingjin
    Rosen, Orli
    Zoog, Stephen J.
    Weng, Haoling H.
    Schweighardt, Becky
    [J]. EBIOMEDICINE, 2018, 37 : 366 - 373